Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-11-30

Clinical Trial Update: Platelet Inhibition in Patients With Systolic Heart Failure [Phase 4]

View source ↗

Summary

Phase 4 trial update on platelet inhibition in patients with systolic heart failure; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Nebraska | Conditions: Systolic Heart Failure | Phase 4 | Status: COMPLETED | Results posted: 2022-11-30